Clinical Trial Update: An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy and safety of long-acting risperidone in adults with schizophrenia or schizoaffective disorder receiving psychiatric home …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Risperidone long-acting injectable (risperidone)

Snippet

Sponsor: Johnson & Johnson Taiwan Ltd | Conditions: Schizophrenia, Schizoaffective Disorders | Phase 4 | Status: COMPLETED